| Market Cap | $36.44M |
| 52-Wk High | $1.30 |
| 52-Wk Low | $1.30 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nextage Therapeutics Ltd market cap is $36.44M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nextage Therapeutics Ltd 52 week high is $1.30 as of September 29, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nextage Therapeutics Ltd 52 week low is $1.30 as of September 29, 2023.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nextage Therapeutics Ltd’s P/E ratio is -6.03.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nextage Therapeutics Ltd P/B ratio is 34.9181.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Nextage Therapeutics Ltd's EBITDA is -3.92.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nextage Therapeutics Ltd 50-day moving average is $1.30.
Nextage Therapeutics Ltd has 42 employees.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.